EU national public outcry Pfizer Delaying the Covid Vaccine Risk affecting confidence

–

EU national public outcry Pfizer Delaying the Covid Vaccine Risk affecting confidence

Reuters reported. On Friday (15 Jan) past Several countries in the European Union (EU) have warned of vaccination programs at risk of losing confidence. After Pfizer – Bion Tech. A vaccine manufacturer against COVID-19. Announced to delay the delivery of the COVID vaccine to the EU according to the number of doses agreed in earlier agreements

The company Pfizer-Bion Tech Has begun delivering the anti-COVID vaccine to the EU since late December. But about nine of the 27 EU nations have complained through a meeting this week about the inadequate delivery of the COVID-19 vaccine from Pfizer-BionTech.

Pfizer originally stated that deliveries of the vaccine would meet the agreed deadline. But on Friday, Pfizer announced it would temporarily delay delivery of the vaccine. That will affect vaccine deliveries from late January to early February. This is because Pfizer has modified the manufacturing process to increase the capacity of the vaccine.

In a joint statement by the EU’s six national health and social affairs ministers, Sweden, Denmark, Finland, Lithuania, Latvia and Estonia, this situation was unacceptable. Not only does it affect the vaccination plan. But also diminish the reliability of the vaccination process.

Germany, Europe’s largest order for Pfizer’s vaccine. Referred to Pfizer’s decision as something surprising and sad. While Canada has also revealed that Canada is also affected. The Canadian vaccine is obtained from Pfizer’s facility in Belgium.

News informs that Pfizer – Bion Tech. Has entered into agreements to supply 600 million doses of the COVID vaccine to European nations this year. It agreed to deliver 75 million doses of the vaccine in the second quarter, while the EU approved Moderna’s COVID-approved vaccine. Manufacturers from the United States as well. That Moderna has started shipping to the EU this week. Moderna will supply 10 million doses of the vaccine to the EU by the end of March and in the second quarter and the third quarter, 35 million doses and 80 million doses this year, but has not yet. Timing

–